BSCL2 and metabolic disease: We tested this approach with metabolic disease genes expressed in adipocytes, identifying and subsequently validating novel interactions between BSCL2 and PLIN1 (protein–protein) as well as CEBPA and AGPAT2 (genetic regulatory).